Pembrolizumab for all PD-L1-positive NSCLC
- PMID: 30955976
- DOI: 10.1016/S0140-6736(18)32559-5
Pembrolizumab for all PD-L1-positive NSCLC
Comment on
-
Placental growth factor testing to assess women with suspected pre-eclampsia: a multicentre, pragmatic, stepped-wedge cluster-randomised controlled trial.Lancet. 2019 May 4;393(10183):1807-1818. doi: 10.1016/S0140-6736(18)33212-4. Epub 2019 Apr 1. Lancet. 2019. PMID: 30948284 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials